Restraint Supply shortages and compounding restrictions Australia is facing widespread shortages of GLP-1 receptor agonists such as semaglutide (Ozempic) and dulaglutide (Trulicity), since late 2022 and has been a major issue which is due to growing demand surpassing production, further affecting type 2 diabetes care, cardiovascular risk reduction and weight management in patients
Preventive effects of procyanidin A2 on glucose homeostasis, pancreatic and duodenal homebox 1, and glucose transporter 2 gene expression disturbance induced by bisphenol A in male mice
Peptide Reconstitution & Concentration Calculator Accurate research peptide concentration, reconstitution and dilution calculations for lyophilised peptides
Amino acid profile after oral nutritional supplementation in hemodialysis patients with protein-energy wasting
503A pharmacies help meet individual patient needs by creating customized medications that are not commercially available, such as when a patient has an allergy to an ingredient in a mass-produced drug or when that drug is in shortage